Red cell distribution width and mortality in carotid atherosclerosis

European Journal of Clinical Investigation

Volumn 46, Issue 2, 2016, Pages 198-204

  Wonnerth, Anna ^a   Krychtiuk, Konstantin A ^a,b   Mayer, Florian J ^a   Minar, Erich ^a   Wojta, Johann ^a,b   Schillinger, Martin ^a   Koppensteiner, Renate ^a   Hoke, Matthias ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Ludwig Boltzmann Cluster for Cardiovascular Research   (Austria)

Author keywords

Atherosclerosis; Carotid artery disease; Mortality; Red cell distribution width

Indexed keywords

ADVERSE OUTCOME; AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR MORTALITY; CAROTID ATHEROSCLEROSIS; CELLULAR DISTRIBUTION; EPIDEMIOLOGICAL DATA; ERYTHROCYTE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RED CELL DISTRIBUTION WIDTH; SURVIVAL RATE; SURVIVAL TIME; AGE; ASYMPTOMATIC DISEASE; BLOOD; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; DIAGNOSTIC IMAGING; DUPLEX DOPPLER ULTRASONOGRAPHY; FEMALE; KAPLAN MEIER METHOD; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGE FACTORS; AGED; ASYMPTOMATIC DISEASES; CAROTID ARTERY DISEASES; CAROTID STENOSIS; ERYTHROCYTE INDICES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 84969402656     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12584     Document Type: Article

References (29)

1. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007;50:40-7.
2. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008;117:163-8.
3. Osadnik T, Strzelczyk J, Hawranek M, Lekston A, Wasilewski J, Kurek A et al. Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease. BMC Cardiovasc Disord 2013;13:113.
4. Yao HM, Sun TW, Zhang XJ, Shen DL, Du YY, Wan YD et al. Red blood cell distribution width and long-term outcome in patients undergoing percutaneous coronary intervention in the drug-eluting stenting era: a two-year cohort study. PLoS ONE 2014;9:e94887.
5. Veeranna V, Zalawadiya SK, Panaich S, Patel KV, Afonso L. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES. Int J Cardiol 2013;168:5156-61.
6. Isik T, Uyarel H, Tanboga IH, Kurt M, Ekinci M, Kaya A et al. Relation of red cell distribution width with the presence, severity, and complexity of coronary artery disease. Coron Artery Dis 2012;23:51-6.
7. Akin F, Kose N, Ayca B, Katkat F, Duran M, Uysal OK et al. Relation between red cell distribution width and severity of coronary artery disease in patients with acute myocardial infarction. Angiology 2013;64:592-6.
8. Dabbah S, Hammerman H, Markiewicz W, Aronson D. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 2010;105:312-7.
9. Kim J, Kim YD, Song TJ, Park JH, Lee HS, Nam CM et al. Red blood cell distribution width is associated with poor clinical outcome in acute cerebral infarction. Thromb Haemost 2012;108:349-56.
10. Morceau F, Dicato M, Diederich M. Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis. Mediators Inflamm 2009;2009:405016.
11. Ghaffari S. Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid Redox Signal 2008;10:1923-40.
12. Wen Y. High red blood cell distribution width is closely associated with risk of carotid artery atherosclerosis in patients with hypertension. Exp Clin Cardiol 2010;15:37-40.
13. Schillinger M, Exner M, Mlekusch W, Sabeti S, Amighi J, Nikowitsch R et al. Inflammation and carotid artery - risk for atherosclerosis study (ICARAS). Circulation 2005;111:2203-9.
14. Mineva PP, Manchev IC, Hadjiev DI. Prevalence and outcome of asymptomatic carotid stenosis: a population-based ultrasonographic study. Eur J Neurol 2002;9:383-8.
15. Mansour MA, Littooy FN, Watson WC, Blumofe KA, Heilizer TJ, Steffen GF et al. Outcome of moderate carotid artery stenosis in patients who are asymptomatic. J Vasc Surg 1999;29:217-25; discussion 25-7.
16. Mansour MA, Mattos MA, Faught WE, Hodgson KJ, Barkmeier LD, Ramsey DE et al. The natural history of moderate (50-79%) internal carotid artery stenosis in symptomatic, nonhemispheric, and asymptomatic patients. J Vasc Surg 1995;21:346-56; discussion 56-7.
17. Durham CA, Ehlert BA, Agle SC, Mays AC, Parker FM, Bogey WM et al. Role of statin therapy and angiotensin blockade in patients with asymptomatic moderate carotid artery stenosis. Ann Vasc Surg 2012;26:344-52.
18. Uyarel H, Ergelen M, Cicek G, Kaya MG, Ayhan E, Turkkan C et al. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis 2011;22:138-44.
19. Sun XP, Chen WM, Sun ZJ, Ding XS, Gao XY, Liang SW et al. Impact of red blood cell distribution width on long-term mortality in patients with ST-elevation myocardial infarction. Cardiology 2014;128:343-8.
20. Johnson RA, Waddelow TA, Caro J, Oliff A, Roodman GD. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood 1989;74:130-8.
21. Means RT Jr, Dessypris EN, Krantz SB. Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J Cell Physiol 1992;150:59-64.
22. Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009;202:321-9.
23. Patel KV, Mohanty JG, Kanapuru B, Hesdorffer C, Ershler WB, Rifkind JM. Association of the red cell distribution width with red blood cell deformability. Adv Exp Med Biol 2013;765:211-6.
24. Fornal M, Wizner B, Cwynar M, Krolczyk J, Kwater A, Korbut RA et al. Association of red blood cell distribution width, inflammation markers and morphological as well as rheological erythrocyte parameters with target organ damage in hypertension. Clin Hemorheol Micro 2014;56:325-35.
25. Vaya A, Alis R, Suescun M, Rivera L, Murado J, Romagnoli M et al. Association of erythrocyte deformability with red blood cell distribution width in metabolic diseases and thalassemia trait. Clin Hemorheol Micro 2014 [Epub ahead of print]..
26. Vaya A, Rivera L, de la Espriella R, Sanchez F, Suescun M, Hernandez JL et al. Red blood cell distribution width and erythrocyte deformability in patients with acute myocardial infarction. Clin Hemorheol Micro 2015;59:107-14.
27. Fukuta H, Ohte N, Mukai S, Saeki T, Asada K, Wakami K et al. Elevated plasma levels of B-type natriuretic peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J 2009;50:301-12.
28. Lappe JM, Horne BD, Shah SH, May HT, Muhlestein JB, Lappe DL et al. Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population. Clin Chim Acta 2011;412:2094-9.
29. Zalawadiya SK, Veeranna V, Panaich SS, Afonso L. Red cell distribution width and risk of peripheral artery disease: analysis of National Health and Nutrition Examination Survey 1999-2004. Vasc Med 2012;17:155-63.